$CORT

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (3m)
—
Win rate (3m)
— (0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Aug 24, 1:28 PM ET
$CORTSEC Form 4bearish
Sold 10,000 @ $116.26 avg · $1,162,572 · 2026-08-17

Form 4: Robb Gary Charles sold CORT

Robb Gary Charles (Chief Business Officer at CORCEPT THERAPEUTICS INC) reported an open-market sale of 10,000 shares of CORT at an average $116.26, roughly $1,162,572, in a Form 4 filed 2026-08-18.

At post $118.10Now $122.25+3.5% since postedas of Aug 24, 1:28 PM ET
1d+0.8%
3d+3.5%
1w+4.6%
1m-2.7%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.